Target intelligence / Profile preview

Lipoteichoic acid and Wall teichoic acid (LTA/WTA)

Target
LTA/WTA
Molecular classification
Cell wall component, Pathogen-associated molecular pattern (PAMP), Other
01

Overview

Teichoic acids (TA) and lipoteichoic acids (LTA) are major anionic glycopolymers found within the cell wall of Gram-positive bacteria, including the Lactobacillus genus. Wall teichoic acids (WTA) are covalently linked to peptidoglycan, while LTAs are anchored to the cytoplasmic membrane via a lipid moiety (Brown et al., 2013). These molecules play critical roles in maintaining cell wall integrity, regulating ion homeostasis, and facilitating bacterial adhesion to host tissues (Swoboda et al., 2010). In the context of Lactobacillus, LTAs are significant immunomodulators that interact with host Pattern Recognition Receptors, specifically Toll-like Receptor 2 (TLR2) (Grangette et al., 2005). This interaction can trigger anti-inflammatory or pro-inflammatory cytokine profiles, contributing to the probiotic effects of these bacteria. While often viewed as beneficial in commensals, LTAs in pathogenic species are potent inflammatory mediators and serve as targets for certain antibiotics like daptomycin. Daptomycin disrupts the cell membrane in an LTA-dependent manner, leading to rapid bacterial cell death (Heidary et al., 2014). Research into Lactobacillus LTAs focuses on their potential to treat inflammatory bowel diseases and allergies through immune system priming.

Other names
Lipoteichoic acidWall teichoic acidLTAWTAGlycerol phosphate polymerRibitol phosphate polymerLactobacillus LTA
02

Mechanism of action

Antibiotics like daptomycin bind to LTA to facilitate membrane insertion and disruption (Heidary et al., 2014). Probiotic LTAs act as agonists for host Toll-like receptor 2 (TLR2) to modulate immune signaling and cytokine production (Grangette et al., 2005).

03

Biological functions

Immune responseCell wall maintenanceIon homeostasisBacterial adhesionOther
04

Disease associations

InfectionInflammationSepsisOther
05

Safety considerations

Induction of systemic inflammationPotential for sepsis-like symptomsOff-target effects on beneficial microbiota (Swoboda et al., 2010)
06

Interacting drugs

Daptomycin

3 more in the full profile.

07

Biomarkers

LTA-specific IgG/IgM levelsTLR2 expression levelsCytokine ratios (IL-10/IL-12) (Grangette et al., 2005)

Beyond the preview

Go deeper on Lipoteichoic acid and Wall teichoic acid (LTA/WTA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipoteichoic acid and Wall teichoic acid (LTA/WTA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call